A novel fusion protein of IP10-scFv retains antibody specificity and chemokine function

Biochemical and Biophysical Research Communications
Jun-Qing GuoShang-You You

Abstract

We combined the specificity of tumor-specific antibody with the chemokine function of interferon-gamma inducible protein 10 (IP-10) to recruit immune effector cells in the vicinity of tumor cells. A novel fusion protein of IP10-scFv was constructed by fusing mouse IP-10 to V(H) region of single-chain Fv fragment (scFv) against acidic isoferritin (AIF), and expressed in NS0 murine myeloma cells. The IP10-scFv fusion protein was shown to maintain the specificity of the antiAIF scFv with similar affinity constant, and bind to the human hepatocarcinoma SMMC 7721 cells secreting AIF as well as the activated mouse T lymphocytes expressing CXCR3 receptor. Furthermore, the IP10-scFv protein either in solution or bound on the surface of SMMC 7721 cells induced significant chemotaxis of mouse T cells in vitro. The results indicate that the IP10-scFv fusion protein possesses both bioactivities of the tumor-specific antibody and IP-10 chemokine, suggesting its possibility to induce an enhanced immune response against the residual tumor cells in vivo.

References

Feb 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S D GilliesR A Reisfeld
Jul 1, 1995·The Journal of Experimental Medicine·A L AngiolilloG Tosato
Sep 1, 1993·The Journal of Experimental Medicine·A D Luster, P Leder
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·C SgadariG Tosato
Oct 31, 1996·Annals of the New York Academy of Sciences·A L AngiolilloG Tosato
Jul 1, 1995·Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·G L GraziG Gozzetti
Feb 12, 1998·The New England Journal of Medicine·A D Luster
Sep 3, 1998·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·M L PenichetS L Morrison
Sep 17, 1998·Journal of Leukocyte Biology·C KaneganeG Tosato
Mar 8, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·I NarvaizaJ Prieto
Jun 3, 2000·Annual Review of Immunology·D Rossi, A Zlotnik
Aug 26, 2000·Current Opinion in Chemical Biology·M A Cascieri, M S Springer
May 22, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·U PertlH N Lode
Jan 5, 2002·Cancer Immunology, Immunotherapy : CII·D A ArenbergR M Strieter
Jul 5, 2003·Journal of Immunotherapy·Jiali LiAlan L Epstein

❮ Previous
Next ❯

Citations

Sep 6, 2012·Immunotherapy·Elham Mohit, Sima Rafati
Apr 21, 2009·Biotechnology Advances·Nina E Weisser, J Christopher Hall
May 30, 2014·Experimental Biology and Medicine·Christian Hess, Dario Neri
Oct 30, 2020·Journal of Biomolecular Structure & Dynamics·Mozafar MohammadiNeda Zarei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.